Cibus Global LLC Cash Flow Conversion Efficiency
Cibus Global LLC cash flow conversion efficiency. Based on the latest financial reports, Cibus Global LLC (CBUS) has a cash flow conversion efficiency ratio of -0.636x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.41 Million) by net assets ($14.80 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cibus Global LLC (2015–2025)
Cash flow conversion efficiency of Cibus Global LLC from 2015 to 2025. This chart illustrates how Cibus Global LLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CBUS share price today for real-time trading data and today's change.
Cibus Global LLC Cash Flow Conversion Ratio Explained
Cibus Global LLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cibus Global LLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cibus Global LLC ranked by their cash flow conversion efficiency. Also see CBUS market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bundamedik Tbk PT
JK:BMHS
|
0.083x |
|
Beazley plc
LSE:BEZ
|
0.050x |
|
Nicola Mining Inc. American Depositary Shares
NASDAQ:NICM
|
-3.612x |
|
MIC Electronics Limited
NSE:MICEL
|
0.001x |
|
Urbas Grupo Financiero SA
MC:UBS
|
0.020x |
|
AptaBio Therapeutics Inc
KQ:293780
|
-0.061x |
|
M&G Plc
LSE:MNG
|
0.299x |
|
Y.C.C. Parts MFG Co Ltd
TW:1339
|
0.041x |
Annual Cash Flow Conversion Efficiency for Cibus Global LLC (2015–2025)
The table below shows the annual cash flow conversion efficiency of Cibus Global LLC from 2015 to 2025. Review Cibus Global LLC financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $21.83 Million | $-50.59 Million | -2.318x | -290.63% |
| 2024-12-31 | $97.83 Million | $-58.04 Million | -0.593x | -334.34% |
| 2023-12-31 | $338.29 Million | $-46.21 Million | -0.137x | +94.90% |
| 2022-12-31 | $7.23 Million | $-19.36 Million | -2.677x | -101.13% |
| 2021-12-31 | $14.13 Million | $-18.81 Million | -1.331x | -12.39% |
| 2020-12-31 | $36.88 Million | $-43.67 Million | -1.184x | -131.70% |
| 2019-12-31 | $62.51 Million | $-31.95 Million | -0.511x | -135.73% |
| 2018-12-31 | $93.40 Million | $-20.25 Million | -0.217x | +2.52% |
| 2017-12-31 | $57.48 Million | $-12.79 Million | -0.222x | +68.41% |
| 2016-12-31 | $13.12 Million | $-9.24 Million | -0.704x | -155.26% |
| 2015-12-31 | $24.26 Million | $-6.69 Million | -0.276x | -- |
About Cibus Global LLC
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-th… Read more